Orchid takes ECB route to buy back FCCBs
Orchid Chemicals & Pharmaceuticals has opted for the ECB (external commercial borrowing) route to partly buyback its foreign currency convertible bonds (FCCBs) that were available on huge discounts...
View ArticleOrchid Chem to diversify portfolio
Mumbai: Orchid Chemicals and Pharmaceuticals, the Chennai-based pharma company, is looking at increasing its focus on antibiotics such as penicillin injections and carbapenems to reduce its dependence...
View ArticleOrchid gets USFDA approval for migraine drug
MUMBAI: Drug firm Orchid Chemicals & Pharmaceuticals today said it has received final US regulatory approval for its drug Sumatriptan Succinate tablets used for the treatment of migraine attacks....
View ArticleOrchid Chem gets US nod for insomnia drug
MUMBAI: Orchid Chemicals & Pharmaceuticals Ltd said on Friday the US Food and Drug Administration has approved its generic zaleplon capsules in multiple strengths. The drug is used to treat insomnia.
View ArticleOrchid Pharma settles patent row with Schering-Plough
Chennai-based Pharma major Orchid Chemicals & Pharmaceuticals today said that it has settled patent litigation with Schering-Plough Corp SGP.N, a US-based drug maker. The issue was related to...
View ArticleOrchid plans ECB to buy back FCCBs
Chennai: Chennai-based Orchid Chemicals & Pharmaceuticals Ltd will raise overseas debt to retire $175 million (around Rs 858 crore) in foreign currency convertible bonds (FCCBs). An enabling...
View ArticleOrchid gets ANDA's final nod from USFDA for Zaleplon Capsules
Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the final Abbreviated New Drug Application (ANDA) approval for its Zaleplon capsules from the US Food and Drug...
View ArticleOrchid to bloom on new verticals
Orchid Chemicals & Pharmaceuticals expects to log at least a 20 per cent year-on-year growth for the next three years as more verticals of the company have started generating revenue. Orchid had...
View ArticleOrchid Chem gets US FDA nod for anti-hypertensive drug
Drug maker Orchid Chemicals & Pharmaceuticals today said it has received approval from the US drug regulator for its anti-hypertensive tablets. The company has received approval from the US Food...
View ArticleAward for Orchid’s Aurangabad unit
CHENNAI: Orchid Chemicals & Pharmaceuticals said that its carbapenem API manufacturing facility at Aurangabad had been conferred the Facility of the Year Award (FOYA) in the regional excellence...
View ArticleOrchid gets USFDA nod for injection, gets 6-mth exclusivity
MUMBAI: Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam injection, used to treat infections caused by...
View Article
